To evaluate the development of de novo heart disease after renal injury, we determined expression levels of atrial natriuretic peptide (Anp), brain natriuretic peptide (Bnp), and smooth muscle actin alpha 2 (Acta2), which are sensitive markers of hemodynamic burden and cardiac remodeling [20]. The gene discussed is NPPA; the disease is heart disorder.